Susquehanna Fundamental Investments, LLC Repligen Corp Transaction History

Susquehanna Fundamental Investments, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$162.42 - $220.56 $5.17 Million - $7.02 Million	-31,822 Reduced 51.14%	30,399 $5.15 Million
Q3 2022 Nov 14, 2022	BUY	$160.42 - $256.21 $869,155 - $1.39 Million	5,418 Added 9.54%	62,221 $11.6 Million
Q1 2022 May 16, 2022	BUY	$161.19 - $257.96 $8.51 Million - $13.6 Million	52,791 Added 1315.83%	56,803 $10.7 Million
Q3 2021 Nov 15, 2021	SELL	$194.77 - $324.21 $2.32 Million - $3.86 Million	-11,900 Reduced 74.79%	4,012 $1.16 Million
Q2 2021 Aug 11, 2021	SELL	$165.87 - $220.95 $4.09 Million - $5.45 Million	-24,688 Reduced 60.81%	15,912 $3.18 Million
Q2 2020 Aug 14, 2020	BUY	$94.33 - $140.48 $3.83 Million - $5.7 Million	40,600 New	40,600 $5.02 Million

487

54.4M

341K

235K

Ticker RGEN
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 55,491,200
Market Cap $6.92B
Description
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....

Get notified when there are updates to the investment portfolio of Susquehanna Fundamental Investments, LLC, based on Form 13F filings with the SEC.

Stay updated on Susquehanna Fundamental Investments, LLC with notifications on news.